等待开盘 11-04 09:30:00 美东时间
-0.110
-0.86%
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
10-29 09:25
Clear Street analyst Mickey Schleien initiates coverage on MSC Income Fund (NYSE:MSIF) with a Buy rating and announces Price Target of $15.
10-28 17:34
今日重点评级关注:摩根士丹利:上调Alvotech评级至"超配",目标价14美元;蒙特利尔银行:维持PG&E"跑赢大市"评级,目标价从23美元升至25美元
10-15 18:20
UBS maintains MSC Income Fund (NYSE:MSIF) with a Neutral and lowers the price target from $15.5 to $14.5.
10-15 00:36
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从19美元升至20美元;Ascendiant Capital:维持Plus Therapeutics"买入"评级,目标价从20.5美元升至21美元
10-07 15:04
Keefe, Bruyette & Woods analyst Paul Johnson upgrades MSC Income Fund (NYSE:MSIF) from Market Perform to Outperform and maintains the price target from $16.5 to $16.5.
10-07 00:36
今日重点评级关注:瑞银:上调Gossamer Bio评级至"买入",目标价从1.25美元升至9美元;Canaccord Genuity:维持Corcept Therapeutics"买入"评级,目标价从137美元升至140美元
09-11 10:06
RBC Capital analyst Kenneth Lee maintains MSC Income Fund (NYSE:MSIF) with a Outperform and lowers the price target from $18 to $16.
09-10 22:08
Truist Securities analyst Mark Hughes maintains MSC Income Fund (NYSE:MSIF) with a Buy and lowers the price target from $20 to $19.
08-15 20:33
UBS maintains MSC Income Fund (NYSE:MSIF) with a Neutral and raises the price target from $15.5 to $16.5.
07-16 23:32